HARRISBURG — The majority chairman of the House Health Committee has announced plans for legislation to give the Department of Health greater oversight of lab testing of marijuana sold in the state’s medical marijuana dispensaries.

The move comes after years of controversy over how the industry should test medical marijuana. The Department of Health got the Independent Regulatory Review Commission last year to approve new regulations that would have required marijuana to be tested by two separate labs before it could be sold in the dispensaries. However, a number of marijuana businesses sued in state court to get the two-lab rule tossed. Commonwealth Court sided with the industry earlier this summer. The Department of Health is appealing that decision but for the time being the two-lab rule is not in effect.

As a result, “two tests are still performed, but they are almost always done by the same lab. The two tests occur at different stages in the process,” according to information provided by DOH.

State Rep. Dan Frankel, D-Squirrel Hill, has circulated a cosponsor memo indicating he will introduce legislation aimed at providing the Department of Health with the ability to verify the processes being used by labs testing medical marijuana and confirm their results.

Advertise with us

“Under my bill, labs will be required to report to the Department their standard operating procedures, and the Department will be required to institute a process to check the validity of results,” Mr. Frankel said in the cosponsor memo.

A representative from the Department of Health press office said the agency is not commenting on Mr. Frankel’s proposal because the bill hasn’t been introduced yet so Shapiro administration officials haven’t had a chance to review the language of the legislation.

DOH’s move to require marijuana businesses to use two labs was intended “to create checks and balances, but we heard from suppliers that it was overly cumbersome and from DOH that they’d like stronger oversight of the labs themselves in order to ensure the safety of the product,” Mr. Frankel said in an email Thursday.

The Department of Health maintains that there have been no “widespread or unexpected issues in the testing of medical marijuana,” but officials in the agency argued for the need for greater scrutiny of testing by pointing to controversies over inflated THC levels on marijuana products in other states, as well as concerns about detecting mold in marijuana products.

Mr. Frankel said his legislation would be intended to proactively prevent those types of problems.

“We’ve seen too many problems in other states, like improper reporting of THC content, and even polluted products that have led to product recalls. My bill will empower DOH oversight of laboratories so that the products that make it onto Pennsylvania shelves are safe for consumers, who can then trust what’s on the label. I'm hopeful that requiring lab protocols and allowing for lab testing can get us to that point, making the two lab system unnecessary,” he said.